Pharmaceutical compositions for the treatment of cancer
AssigneeSeleq Oy
InventorsMikael Björnstedt, Adnane Achour, Hugh Salter, Tatiana Sandalova
Life of this patent
Estimating the term…
Abstract
A chemotherapeutically active pharmaceutical composition includes at least one pharmaceutically acceptable seleno amino acid derivative compound for use in the treatment of liver or pancreas cancer, wherein the chemotherapeutically active pharmaceutical composition is used in combination with an agent capable of increasing cytotoxicity of the seleno amino acid derivative compound.
Claims19
A chemotherapeutically active pharmaceutical composition comprising at least one pharmaceutically acceptable seleno amino acid derivative compound for use in the treatment of liver or pancreas cancer, wherein said chemotherapeutically active pharmaceutical composition is used in combination with an agent capable of increasing cytotoxicity of the seleno amino acid derivative compound.
A mutant kynurenine aminotransferase I or III protein having increased beta-elimination activity or a nucleic acid sequence coding for such a mutant protein.
A method for treating liver or pancreas cancer, comprising administration of:
- a) a chemotherapeutically active pharmaceutical composition comprising at least one pharmaceutically acceptable seleno amino acid derivative compound, and
- b) an agent capable of increasing cytotoxicity of the seleno amino acid derivative compound.
Dependencies are inferred from the claim text.